This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erdogan, M. F. Articles by Erdogan, G. i Search for Related Content PubMed PubMed Citation Articles by Erdogan, M. F. Articles by Erdogan, G. i

Omeprazole: Calcitonin Stimulation Test for the Diagnosis Follow-Up and Family Screening in Medullary Thyroid Carcinoma

Murat Faik Erdoan, Sevim Güllü, Nilgün Bakal, Ali Riza Uysal, Nuri Kamel and Gürbüz i Erdoan

Department of Endocrinology and Metabolism (M.F.E., S.G., N.B., A.R.U., N.K., G.E.) University of Ankara, School of Medicine, Ankara, Turkey

Address correspondence and requests for reprints to: Gürbüz Erdoan MD PhD, Merutiyet Cad. 29/3, Kizilay 06420, Ankara, Turkey.

Medullary thyroid carcinoma (MTC) occurs sporadically but may also be inherited as part of the multiple endocrine neoplasia (MEN) type 2 syndrome. Screening of the patients and first degree relatives annually with basal and provocative tests for serum immunoreactive calcitonin (CT) levels is essential and enables potentially curative disease. Pentagastrin and calcium are the usual provocative agents used worldwide. We used endogenous gastrin (GT) release achieved by omeprazole, 20 mg b.i.d., to stimulate CT in 9 MTC, in 3 MEN 2A family members, and in 50 healthy control subjects. A steady and significant increase both in GT and CT levels was achieved in 9 MTC patients and 3 of the 14 family members tested, whereas in healthy controls the CT increase stimulated by GT was insignificant.

Preliminary results showed that this new, safe, cheap, and outpatient-basis test can be used in MTC diagnosis, follow-up, and screening.

This article has been cited by other articles:

				L. Hegedus, S. J. Bonnema, and F. N. Bennedbaek Management of Simple Nodular Goiter: Current Status and Future Perspectives Endocr. Rev., February 1, 2003; 24(1): 102 - 132. [Abstract] [Full Text] [PDF]

				G. Vitale, A. Ciccarelli, M. Caraglia, M. Galderisi, R. Rossi, S. Del Prete, A. Abbruzzese, and G. Lupoli Comparison of Two Provocative Tests for Calcitonin in Medullary Thyroid Carcinoma: Omeprazole vs Pentagastrin Clin. Chem., September 1, 2002; 48(9): 1505 - 1510. [Abstract] [Full Text] [PDF]